Skip to main content

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • KemPharm, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted a fee waiver and has refunded the full user fee amount of $2,374,200 for its New Drug Application (NDA) filing for KP201/APAP, the Company’s investigational immediate release combination of its hydrocodone prodrug, KP201 (benzhydrocodone hydrochloride), and acetaminophen (APAP), which is currently under priority review by the FDA.  The FDA has set a target action date under the Prescription Drug User Fee Act of June 9, 2016.

  • MediciNova, Inc., and the JASDAQ Market of the Tokyo Stock Exchange announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a pending patent application which covers MN-001 (tipelukast) and MN-002 (a major metabolite of MN-001) for the treatment of hypertriglyceridemia, hypercholesterolemia, and hyperlipoproteinemia.

  • Focusing majorly on health, the Delhi government on Monday hiked its budgetary allocation for public health by Rs.472 crore over last year, and proposed a three-tier health system with opening of 1,000 mohalla (community) clinics and 150 polyclinics in various parts of the city.

  • The Chilean health ministry has confirmed the first case of sexually transmitted Zika virus in the country, the media reported on Sunday.The 46-year-old woman was infected with the virus as she had unprotected sex with her partner, who was infected with Zika in Haiti, said the ministry on Saturday.

  • Pregnant women with higher blood levels of a common plastic chemical used in the coatings of food containers are more likely to deliver their babies early compared with women with lower levels of that chemical, says a study led by an Indian-origin researcher.

Subscribe to Pharma News